Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)

NCT04748042 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Castrate Sensitive Prostate Cancer
Oligometastatic Disease

Interventions

DRUG: Abiraterone
DRUG: Prednisone
RADIATION: External Beam Radiotherapy
BIOLOGICAL: Androgen Deprivation Therapy (ADT)
DRUG: Olaparib

Sponsor

University of Michigan Rogel Cancer Center